sglt2抑制剂在1型糖尿病中的应用:来自葡萄牙三级医疗中心的经验

{"title":"sglt2抑制剂在1型糖尿病中的应用:来自葡萄牙三级医疗中心的经验","authors":"Mariana Aveiro-Lavrador, B. Araujo, M. Melo, L. Barros, I. Paiva","doi":"10.26497/ao220037","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":41840,"journal":{"name":"Revista Portuguesa de Endocrinologia Diabetes e Metabolismo","volume":"2 1","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"USE OF SGLT2 INHIBITORS IN TYPE 1 DIABETES: EXPERIENCE FROM A PORTUGUESE TERTIARY CENTER\",\"authors\":\"Mariana Aveiro-Lavrador, B. Araujo, M. Melo, L. Barros, I. Paiva\",\"doi\":\"10.26497/ao220037\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":41840,\"journal\":{\"name\":\"Revista Portuguesa de Endocrinologia Diabetes e Metabolismo\",\"volume\":\"2 1\",\"pages\":\"\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Portuguesa de Endocrinologia Diabetes e Metabolismo\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.26497/ao220037\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Portuguesa de Endocrinologia Diabetes e Metabolismo","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26497/ao220037","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}